INTRODUCTION {#sec1-1}
============

During the past decade, the incidence of diabetes mellitus has increased and led to a threatening epidemic.\[[@ref1][@ref2]\] This increased incidence is associated with higher rate of complications including foot problems and ulcer healing difficulties, which are clinically significant and challenging.\[[@ref3][@ref4][@ref5]\] Diabetes is considered as the major cause of non-traumatic lower extremity amputation that reduces the survival of patients, and causes an enormous burden to the society.\[[@ref6][@ref7]\]

To improve the diabetic foot ulcer healing process, many biomedical studies have been carried out, and different preparations have been studied.\[[@ref8]\] Over the previous century, different herbal compounds have been developed in Africa and Asia for ulcer healing.

The kiwifruit is originated from China, and it has been known there since 700 years ago. Later, it was introduced to New Zealand and America. It is believed that this fruit contains potent protein-dissolving enzymes (actinidin), ascorbic acid (a scavenger agent) and antibacterial agents; therefore, it can play an important role in ulcer healing process.\[[@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16]\]

Several *in vitro* and animal studies reported that the kiwifruit has proven effects in ulcer debridement, angiogenesis and disinfection.\[[@ref11][@ref17][@ref18][@ref19]\]

Given the above evidence, this study was purposed to evaluate the effect of kiwifruit on healing of neuropathic diabetic foot ulcers.

MATERIALS AND METHODS {#sec1-2}
=====================

Study design and patients {#sec2-1}
-------------------------

In this randomized clinical trial patients with neuropathic diabetic foot ulcer referred to Al-Zahra hospital clinic, affiliated to Isfahan University of Medical Sciences, from 2009 to 2010 were enrolled.

Sixty-four patients were initially evaluated. Twenty patients were excluded for not meeting the study criteria and 4 were excluded because of declining participation. Finally, 40 patients were randomly allocated to the experimental or control groups using an online application (<http://www.randomizer.org>) \[[Figure 1](#F1){ref-type="fig"}\].

![Study flow diagram](JRMS-19-520-g001){#F1}

Inclusion criteria of the patients for the study were based on clinical diagnosis of neuropathic diabetic foot ulcer and the signing informed consent. Diagnosis of neuropathy was confirmed using a 5.07/10 gram monofilament. In addition, all patients underwent palpation of the foot pulses and Doppler sonography to assess foot blood supply, and those with ischemic ulcers were excluded from the study. Patients who had received any treatment for diabetic foot ulcer within 6 months of the study were also excluded.

The ethics committee of Isfahan University of Medical Sciences approves this study (Research project number; 390023), and the informed consent was obtained from all patients included in this study.

Procedure {#sec2-2}
---------

All patients were initially admitted to the hospital. To make a pre-intervention histological assessment, a tissue sample was taken from the ulcer site under local anesthesia. Moreover, to determine the initial size of the lesion, a baseline photo of the lesion was taken.

Then, all the patients received standard treatments including surgical debridement, oral antibiotic --- ciprofloxacin 500 mg (Chemidarou-Iran) every 12 hours and clindamycin 600 mg (Chemidarou-Iran) every 8 hours, blood sugar control was monitored and the regular sterile ulcer dressing was done, after washing the ulcer with sterile normal saline. When the ulcers showed no signs of infection based on the culture results, patients were discharged from the hospital, but a daily visit was arranged to assess the ulcer and to perform debridement on a regular basis.

Patients of the control group received only the standard treatment, and the ulcer dressing was changed thrice a day. Patients in the experimental group received the standard treatment and an additional treatment, which is as follows; the ulcers of the experimental group were covered with a 3-mm-thick layer of a mixture of pulped fresh kiwifruit and pure-normal concentration-kiwifruit extract, using a 50 cc gavage syringe. Both the mixture and the extract were provided from the natural fruit (without any additive).

The ulcers of the experimental group were washed with sterile normal saline every 12 hours. Then, they were covered again with kiwifruit, and were dressed with sterile gauze and latex-free tape.

All wound dressings were performed by trained and experienced nurses during hospitalization, and thereafter.

All macroscopic, histopathologic and microbiologic changes of the ulcers in both groups were observed and recorded during the study. Regarding the macroscopic properties, any change in the ulcer size, degree of edema, hyperemia, and epithelialization status were assessed every other day. Furthermore, on each visit, a digital photo of the lesion was taken to record the ulcer size and check the healing progress. Photos were analyzed by SigmaScan pro software, version 5.0, to determine the ulcer size.

After 21 days, a post-intervention biopsy was taken, and an ulcer culture was obtained to check the histopathological and microbiological statuses, respectively. The ulcer cultures were studied based on the presence of *Pseudomonas-aeruginosa*, *Staphylococcus aureus*, coagulase-negative *Staphylococcus*, *Streptococcus* and other gram-negative bacteria (such as *Enterobacter* and *Klebsiella*).

Both pre- and post-intervention biopsies were studied by the same pathologist who was not aware of the samples' group. Samples were assessed regarding the degree of epithelialization, degree of angiogenesis, degree of tissue granulation, collagen deposition status and acute or chronic inflammatory cell count. Epithelialization, inflammation, granulation, and vascularization were investigated based on the scoring system presented in [Table 1](#T1){ref-type="table"}.\[[@ref20][@ref21]\]

###### 

Histopathological wound healing scale
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Statistical analysis {#sec2-3}
--------------------

Data were analyzed by the Statistical Package for the Social Sciences (SPSS) 20.0 (SPSS Inc., Chicago, IL, USA) software and Wilcoxon, Mann-Whitney, independent-*t* test and Chi-square tests. *P* values less than 0.05 were considered as the level of significance.

RESULTS {#sec1-3}
=======

After exclusion of 3 patients from the experimental group due to non-compliance in blood sugar control, data of the other 17 patients in this group was compared with 20 patients of the control group. There were no significant differences in the baseline characteristics of two studied groups \[[Table 2](#T2){ref-type="table"}\].

###### 

Baseline characteristics of experimental and control groups

![](JRMS-19-520-g003)

The ulcers were assessed regarding changes in macroscopic, histopathological and microbiological properties.

Macroscopic findings {#sec2-4}
--------------------

### Ulcer size {#sec3-1}

A more significant reduction in the ulcer size was found in the experimental group compared with the control group (168.11 ± 22.31 *vs.* 88.80 ± 12.04 mm^2^ respectively, *P* \< 0.0001).

### Macroscopic hyperemia and edema {#sec3-2}

Although the experimental group showed macroscopically more hyperemia on the day 3 and 5 (25.33 ± 8.06 *vs.* 22.40 ± 6.09 arbitrary units (AU), p: 0.08); after the 11^th^ day, hyperemia was more evident in the control group (32.08 ± 4.99 *vs.* 27.31 ± 5.78, p: 0.02).

Wound closure {#sec2-5}
-------------

Applying kiwifruit accelerated wound closure. Wound closure occurred 11.24 ± 3.66 days after starting the intervention in the experimental group, which was significantly sooner than the control group (17.76 ± 4.88 days) (*P* \< 0.0001).

Microscopic findings {#sec2-6}
--------------------

Pre- and post-interventions, histopathological properties of the ulcers are compared in [Table 3](#T3){ref-type="table"}.

###### 

Pre- and post-intervention histopathological characteristics of experimental and control groups
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Microbiological findings {#sec2-7}
------------------------

The rate of positive bacterial culture at the beginning of the study was 72% and 83% in experimental and control groups, respectively. After intervention, reduction in positive bacterial cultures was not different in two studied groups (44% in experimental group *vs.* 67% in control group, *P* = 0.18).

No major side effect was found or reported during the study.

DISCUSSION {#sec1-4}
==========

Diabetic foot ulcer is a common, expensive and debilitating problem among diabetic patients that may lead to lower limb amputation. Therefore, several different methods have been studied to achieve better results in the treatment of this sort of ulcers.\[[@ref6][@ref7]\]. Herbal products have been widely used in treatment of different types of wound for centuries.\[[@ref22]\] For instance, these preparations were used for chemical wound debridement during World War II.\[[@ref23]\] Similarly, different herbal compounds have been reported to be effective in the treatment of diabetic foot ulcers.\[[@ref24][@ref25][@ref26][@ref27][@ref28][@ref29]\] Although there is no study regarding the effectiveness of kiwifruit on diabetic foot ulcers, the previous animal study states that reported kiwifruit is a safe and effective method for wound healing in animal models.\[[@ref18]\] We carried out a pilot study on patients with neuropathic diabetic foot ulcers for the first time, and found it to be beneficial.

Patients treated with kiwifruit had significantly sooner scar tissue detachment. This effect may be related to some of the ingredients of kiwifruit including ascorbic acid, which works as a scavenger agent, and actinidin, which is a strong protein dissolving enzyme.\[[@ref19][@ref30]\] Actinidin is a sort of cystein proteases (CPs) found in kiwifruit. This enzyme is responsible for well-known proteolytic and meat-tenderizing effect of kiwi, and makes this fruit a good option for herbal debridement.\[[@ref18][@ref31]\] This finding confirms the suggested role for kiwifruit in the previous study as a herbal debridement agent.\[[@ref30]\]

Better vascularization that was found in the experimental group is similar to animal findings.\[[@ref32]\] Although several plants such as aloe vera are reported to have angiogenic compounds, there is no report about angiogenic properties of kiwifruit.\[[@ref18]\] Hence, it is assumed that kiwifruit may be a rich source of some sorts of angiogenesis modulators that are necessary for healing process.\[[@ref32]\]

The combination of scar tissue detachment and angiogenesis effects of kiwifruit could explain its effect on hyperemia. These effects lead to more hyperemia during the first half when the scavenger and debridement effects are dominant; however, in the second part, hyperemia is less evident in the experimental group probably due to better progress of the healing process.

In addition to macroscopic improvement, histological evaluation of foot ulcers showed that kiwifruit dressing significantly increases granulation score, epithelialization score and collagen formation. It decreases inflammation of the ulcer site. These microscopic changes need further biochemical investigations to confirm the definite mechanisms involved in these processes.

Given the above evidence, it is not surprising to find a significant reduction in the size of the foot ulcers treated with kiwifruit.

Because wound infection is a common problem in patients with diabetic foot ulcer, infection control is a very important issue in these patients. Previous studies reported significant antibacterial properties for kiwifruit.\[[@ref19][@ref32]\] It may be attributed to the composing ingredients of kiwifruit. High concentration of CPs in different fruits like kiwi may be responsible for their antibacterial, antifungal and even anti-insect effects.\[[@ref19][@ref31]\] *In vitro* studies reported that the kiwifruit extract have antibacterial effects against Gram-positive and Gram-negative bacteria.\[[@ref19][@ref33]\] In contrast to the previous studies, we did not find any difference between the two groups that confirm antimicrobial effects of kiwifruit. This contradiction may be due to administration of oral antibiotics to all patients as a part of standard treatment. Antibiotics can hide the antibacterial effects of kiwifruit.

A major concern during the treatment with herbal medications is the unpredicted side effects such as allergic reactions. Fortunately, similar to the previous study on rats,\[[@ref32]\] no major side effects were observed in patients treated with kiwifruit.

Based on the useful properties of kiwifruit including debridement of devitalized tissue and detachment of the scar tissue --- without detrimental effects on the healing process; improvement of angiogenesis, epithelialization, and granulation; and its effect on reducing the ulcer size, this pilot study suggests that applying kiwifruit on neuropathic diabetic foot ulcers could be a promising way to achieve better outcomes.
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